Nxera Pharma
4565.T
$4.98
Share price
-5.05%
Change (1 day)
-52.51%
Change (1 year)
Categories
Earnings for Nxera Pharma (4565.T)
Earnings in 2024 (TTM): -$49.8 Million USD
According to Nxera Pharma's latest financial reports the company's current earnings are $0.15 Billion USD. In 2023 the company made an earning of -$55.99 Million USD a decrease over its 2022 earnings that were of $12.32 Million USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Nxera Pharma from 2009 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | -$49.8 Million | -11.05% |
| 2023 | -$55.99 Million | -554.21% |
| 2022 | $12.32 M | -65.55% |
| 2021 | $35.77 M | 55.15% |
| 2020 | $23.06 M | 32.03% |
| 2019 | $17.46 M | -125.06% |
| 2018 | -$69.7 Million | 477.04% |
| 2017 | -$12.08 Million | -110.25% |
| 2016 | $0.11 B | 207.42% |
| 2015 | $38.31 M | 210.37% |
| 2014 | $12.34 M | 311.29% |
| 2013 | $3 M | -125.21% |
| 2012 | -$11.91 Million | -52.58% |
| 2011 | -$25.11 Million | 16.15% |
| 2010 | -$21.62 Million | 17.66% |
| 2009 | -$18.38 Million |